To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:34 Issue:1 Number:1 ISSN#:2564-2537
Meta-Analysis
ACE Report #13570
Ace Report Cover General Orthopaedics

Zoledronic Acid After Percutaneous Kyphoplasty for Osteoporotic Fx Improves Pain, Disability & BMD


How to Cite

OrthoEvidence. Zoledronic Acid After Percutaneous Kyphoplasty for Osteoporotic Fx Improves Pain, Disability & BMD. ACE Report. 2021;34(1):1. Available from: https://myorthoevidence.com/AceReport/Report/13570

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Clinical efficacy of zoledronic acid combined with percutaneous kyphoplasty in the prevention and treatment of osteoporotic vertebral compression fracture: A systematic review and meta-analysis

Medicine (Baltimore). 2021 Apr 2;100(13): e25215.

Contributing Authors:
K Li H Gong R Xie J Gu S Wang C Lin J Yin X Hou Q Zhang L Li Y Hao

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Eight randomized controlled trials including 578 patients with osteoporotic vertebral compression fracture who underwent percutaneous kyphoplasty were randomized to undergo zoledronic acid injections (n=285) or no treatment (n=293). Primary outcomes included bone mineral density (BMD), pain on the visual analogue scale (VAS), disability using the Oswestry Disability Index (ODI), incidence of recom...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.